Panacea Biotec Limited — Important, 07-04-2025: Updates

No shares have been dematerialized in March 2025 for Panacea Biotec Ltd. As of the end of March, a total of 6,10,94,525 shares were in dematerialized form, comprising 5,23,17,806 from NSDL and 87,76,719 from CDSL. This stability in the dematerialization status indicates no significant movement in share conversions during the month, which could reflect investor sentiment or operational factors. Observers should keep an eye on share activity trends, as changes might impact liquidity or market strategy moving forward.